Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO

NCT03892434 is registered in ClinicalTrials.gov with Yeungnam University College of Medicine as lead sponsor.

NCT NCT03892434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03892434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO
Lead sponsor
Yeungnam University College of Medicine
Phase
Phase 4
Overall status
Unknown status
Start date
March 18, 2019
Completion date
June 18, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

branch retinal vein occlusion with macular edema